$MRKR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Marker Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Marker Therapeutics, Inc.. Get notifications about new insider transactions in Marker Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 20 2009 | TPIV | TAPIMMUNE INC | LINDSAY ALAN P | Director | Option Exercise | J | 0.01 | 162,000 | 1,620 | 162,000 | |
Mar 18 2009 | TPIV | TAPIMMUNE INC | CORIN DENIS | President and CEO | Option Exercise | J | 0.01 | 200,000 | 2,000 | 350,000 | |
Mar 18 2009 | TPIV | TAPIMMUNE INC | CORIN DENIS | President and CEO | Option Exercise | J | 0.01 | 150,000 | 1,500 | 150,000 | |
Jul 31 2008 | TPIV | TAPIMMUNE INC | CORIN DENIS | President and CEO | Option Exercise | J | 0.32 | 1,000,000 | 320,000 | 800,000 | |
Jun 25 2008 | TPIV | TAPIMMUNE INC | CORIN DENIS | President and CEO | Option Exercise | J | 0.32 | 1,000,000 | 320,000 | 1,800,000 | |
Feb 17 2004 | TPIV | TAPIMMUNE INC | GENEMAX CORP | Director | Option Exercise | A | 0.50 | 200,000 | 100,000 | 200,000 | |
Feb 17 2004 | TPIV | TAPIMMUNE INC | GENEMAX CORP | Director | Option Exercise | A | 0.50 | 200,000 | 100,000 | 200,000 | |
Feb 17 2004 | TPIV | TAPIMMUNE INC | GENEMAX CORP | Option Exercise | A | 0.50 | 125,000 | 62,500 | 125,000 | ||
Feb 17 2004 | TPIV | TAPIMMUNE INC | JEFFERIES WILFRED | Chief Scientist Off ... | Option Exercise | A | 0.50 | 1,500,000 | 750,000 | 1,500,000 | |
Feb 17 2004 | TPIV | TAPIMMUNE INC | HANDFORD RONALD L | President/CEO | Option Exercise | A | 0.50 | 200,000 | 100,000 | 200,000 | |
Feb 17 2004 | TPIV | TAPIMMUNE INC | ATKINS GRANT R | Chief Financial Off ... | Option Exercise | A | 0.50 | 250,000 | 125,000 | 250,000 |